Article

Synthesis and Screening of Bicyclic Carbohydrate-Based Compounds: A Novel Type of Antivirals.

Department of Organic Chemistry, Ghent University, Gand, Flemish, Belgium
Bioorganic & Medicinal Chemistry Letters (Impact Factor: 2.33). 04/2006; 16(6):1495-8. DOI: 10.1016/j.bmcl.2005.12.048
Source: PubMed

ABSTRACT A small library of bicyclic carbohydrate derivatives was synthesized and screened. A strong and selective activity against cytomegalovirus was found. Structure-activity relationship for this new type of antivirals is discussed.

0 Followers
 · 
99 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: A large series of alkyl C-glycosides was synthesized from D-glucal or D-galactal. These compounds were screened against the human promyelocytic leukemia cell line (HL60), showing significant activity and apoptosis. Up to 13 C-glucopyranosides, but no C-galacto- or C-mannopyranosides, exhibited inhibitory concentrations (IC(50) values) below 20 microM, five of them in the range 4-8 microM. Preliminary structure-activity relationships were established.
    Bioorganic & Medicinal Chemistry Letters 09/2006; 16(16):4223-7. DOI:10.1016/j.bmcl.2006.05.079 · 2.33 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug discovery has long suffered from the difficulty of having to place pharmacophoric groups in just the right spatial arrangement to elicit the desired biological response. Although some molecule classes have been discovered that seem to be privileged structures for at least some drug-receptor interactions, there remains the challenge to design and synthesize molecules with high specific affinity to pharmacologically important targets. With their high density of stereochemical information and their relative rigidity, carbohydrates provide excellent platforms upon which to display a number of substituents in a sterically defined way, hence offering the opportunity to harness their unique features for the drug-discovery process. This review highlights the progress that has been made in the development of carbohydrate scaffolds for drug discovery.
    ChemMedChem 11/2006; 1(11):1164-94. DOI:10.1002/cmdc.200600150 · 3.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fifty-two C-glycosides were synthesized and their in-vitro antiproliferative activity screened against human cervical carcinoma (HeLa) and osteosarcoma (HOS) cell lines. Nine of them had growth inhibitions (GI50 values) below 10 μM, the C-glucopyranoside 38 being the most active against HeLa (5.4 μM) and the dichlorocyclopropyl derivative 42 against HOS (1.6 μM). Some preliminary structure–activity relationships were established.
    Bioorganic & Medicinal Chemistry Letters 07/2007; 17(13):3676-3681. DOI:10.1016/j.bmcl.2007.04.060 · 2.33 Impact Factor